Optic atrophy following repeated courses of tartar emetic for the treatment of bilharziasis.
D000293:Adolescent; D000818:Animals; D000965:Antimony / Q000009:adverse effects*; D000966:Antimony Potassium Tartrate / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D009896:Optic Atrophy / Q000139:chemically induced*; D012552:Schistosomiasis / Q000188:drug therapy; D014792:Visual Acuity
D000965:Antimony; D000966:Antimony Potassium Tartrate